| INTRODUCTION
Coronary chronic total occlusions (CTOs) are common and have been associated with increased risk for ventricular arrhythmias and adverse clinical outcomes. [1] [2] [3] [4] Several studies, most of which were retrospective, have examined whether CTO revascularization improves symptoms, and most have suggested a benefit. 5, 6 The effect of successful CTO revascularization on left ventricular (LV) systolic function remains unclear, with the only randomized controlled trial performed to date demonstrating no benefit from CTO recanalization in the setting of recent ST-segment elevation acute myocardial infarction. 7 We performed a systematic review and metaanalysis to examine the impact of successful CTO PCI on LV size and ejection fraction (EF).
2 | METHODS
| Data sources and eligibility criteria
Our meta-analysis was conducted and reported according to the proposal for conducting and reporting Meta-analyses of Observational studies (MOOSE) 8 and was registered with the International Prospective Register for Systematic Reviews (PROSPERO: CRD42018084926). We performed a computerized systematic search through MEDLINE, EMBASE, and COCHRANE databases from January 1980 to November 2017 using the following search terms separately and in combination; "CTO," "Chronic total occlusion," "Chronic total coronary occlusion," "revascularization,"
"PCI," "Angioplasty," and "Recanalization." A similar search strategy was performed for abstracts of the major scientific sessions (American College of Cardiology, European Society of Cardiology, American Heart Association) until November 2017. We further screened the bibliographies of the retrieved studies, prior meta-analyses as well as ClinicalTrials.gov for any relevant studies not retrieved through the initial search. Our search was limited to the English language.
We included in this meta-analysis studies that evaluated the impact of successful CTO PCI on LVEF. Studies had to include patients with a CTO (definition of CTO in each study is illustrated in Table 1) who received successful PCI, and the LV function had to have been assessed before and after successful PCI.
| Data extraction and quality assessment
The data were extracted by two independent investigators (MM, MS) including baseline study characteristics, patients' demographic and outcomes of interest from the retrieved studies. Discrepancies among investigators were settled by consensus. The quality of the included studies was assessed using New-Castle Ottawa Scale for cohort studies. 9 
| Outcomes
The primary outcome of the current study was the mean difference in LVEF before and after successful CTO PCI. Subgroup analysis was performed for the primary outcome comparing studies with mean baseline LVEF <50% versus those with mean baseline LVEF of 50% or higher. Further sensitivity analyses included studies that defined CTOs as occlusions of at least 3 month duration, and with follow-up period of at least 3 months, which has been proposed as the minimum time interval required for stunned and hibernating myocardium to recover after revascularization. 12 3 | RESULTS
| Characteristics of the included studies and quality assessment
The study selection process is described in Figure 1 . Our initial search yielded 827 citations. The characteristics of the included studies are described in (Table 1) . Only one randomized-controlled trial (RCT) was identified. Thirty-four observational studies [including two abstracts 13, 14 ] with a total of 2804 patients met our inclusion criteria. Cardiac magnetic resonance imaging (CMR) was used to assess LVEF in nine studies [14] [15] [16] [17] 29, 32, 33, 40, 41 while echocardiography was used in 10 studies. 22, 24, 26, 31, 36, 37, 39, [43] [44] [45] Other studies used left ventriculography 13, 20, 21, 23, 25, 28, 34, 35, 42, 46 or nuclear imaging, 27, 38 or did not specify the method used for assessing LVEF. 18, 19, 30 The 
| Baseline characteristics of the included cohorts
The baseline patient characteristics are described in Table 2 . Mean age was 61 ± 10 years and 80.6% of the patients were men.
Approximately half of the patients had prior myocardial infarction (47%). The CTO target artery was the left anterior descending (LAD) in 43% and the right coronary (RCA) in 40% of patients.
Baseline characteristics and demographics of patients in studies describing LVEF change after failed CTO PCI are described in (Supplementary Table S2 ).
| Outcomes
Successful CTO PCI was associated with a significant increase in LVEF improvement in LVEF after successful CTO PCI, with concomitant improvement in New York Heart Association functional class, angina, and brain natriuretic peptide levels. 16 Moreover, subgroup analyses of other studies have shown that the most improvement of LVEF is achieved when baseline LVEF is below 50%. 13, 17, 19 Some of the studies included in the meta-analysis defined "CTOs" as lesions with <3 months occlusion duration, which is the currently accepted threshold for a lesion to be characterized as CTO. When restricting our analyses to studies with documented CTO duration of at least 3 months and with follow up duration of at least 3 months significant improvement in LVEF was shown (4.31%, 95%CI Finally, we did not evaluate clinical outcomes after successful CTO PCI.
In patients with ischemic cardiomyopathy, Cioffi et al 15 demonstrated
that reverse cardiac remodeling was associated with lower mortality (3%) compared with no reversal (22%). 49 Moreover, In the V-HeFT I and II studies, A 5% increase in ejection fraction was the best predictor of mortality. 50 However, the clinical implications of the 3.8% increase in LVEF and 4 mL decrease in LVESV remain unclear. 
